Yeo YH et al. |
First-line eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis. |
2018 |
Gut |
pmid:27670375
|
Suzuki R et al. |
Sinobronchial syndrome treated as intractable asthma. |
2018 |
Pediatr Int |
pmid:30320426
|
Iannone A et al. |
New fecal test for non-invasive detection: A diagnostic accuracy study. |
2018 |
World J. Gastroenterol. |
pmid:30038469
|
Heffernan CB et al. |
Does Clarithromycin Cause Hearing Loss? A 12-Year Review of Clarithromycin Therapy for Nontuberculous Mycobacterial Lymphadenitis in Children. |
2018 |
Ann. Otol. Rhinol. Laryngol. |
pmid:30032669
|
Hamza D et al. |
Genotyping and antimicrobial resistance patterns of Helicobacter pylori in human and dogs associated with A2142G and A2143G point mutations in clarithromycin resistance. |
2018 |
Microb. Pathog. |
pmid:30031039
|
Vianna JS et al. |
The interplay between mutations in cagA, 23S rRNA, gyrA and drug resistance in Helicobacter pylori. |
2018 |
Rev. Inst. Med. Trop. Sao Paulo |
pmid:29972462
|
Myojin S et al. |
Chronic otitis media caused by Mycobacterium abscessus spp. massiliense treated with tigecycline in a 10-year-old child. |
2018 |
Int. J. Infect. Dis. |
pmid:29966711
|
Liou JM et al. |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection. |
2018 |
Gastroenterology |
pmid:29964036
|
Kwofie SK et al. |
Screening of Isocitrate Lyase for Novel Anti-Buruli Ulcer Natural Products Originating from Africa. |
2018 |
Molecules |
pmid:29954088
|
Tanabe H et al. |
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication. |
2018 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:29950163
|
Sandri A et al. |
Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice. |
2018 |
Virulence |
pmid:29938577
|
Gonzalez-Hormazabal P et al. |
Prevalence of clarithromycin resistance in Helicobacter pylori in Santiago, Chile, estimated by real-time PCR directly from gastric mucosa. |
2018 |
BMC Gastroenterol |
pmid:29925321
|
|
Clarithromycin in patients with coronary artery disease. |
2018 |
Med Lett Drugs Ther |
pmid:29913468
|
Li M et al. |
Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori. |
2018 |
Helicobacter |
pmid:29873436
|
Blümel B et al. |
Retrospective study on outcome of salvage Helicobacter pylori eradication therapies based on molecular genetic susceptibility testing. |
2018 |
Helicobacter |
pmid:29873430
|
Ito M et al. |
Phase transitions of antibiotic clarithromycin forms I, IV and new form VII crystals. |
2018 |
Int J Pharm |
pmid:29864514
|
Jin BH et al. |
Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study. |
2018 |
Eur. J. Clin. Pharmacol. |
pmid:29846770
|
Auesomwang C et al. |
Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication. |
2018 |
J. Gastroenterol. Hepatol. |
pmid:29804294
|
Kusuki M et al. |
Determination of the antimicrobial susceptibility and molecular profile of clarithromycin resistance in the Mycobacterium abscessus complex in Japan by variable number tandem repeat analysis. |
2018 |
Diagn. Microbiol. Infect. Dis. |
pmid:29550059
|
Brennan DE et al. |
Can bacterial virulence factors predict antibiotic resistant infection? |
2018 |
World J. Gastroenterol. |
pmid:29531461
|
Reisfeld L et al. |
Cutaneous mycobacteriosis in a captive Amazonian manatee Trichechus inunguis. |
2018 |
Dis. Aquat. Org. |
pmid:29516862
|
Fiorini G et al. |
Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice. |
2018 |
Eur J Gastroenterol Hepatol |
pmid:29481383
|
Talarico S et al. |
High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR. |
2018 |
Helicobacter |
pmid:29480566
|
Takemori N et al. |
A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus - clinical significance and possible mechanisms: a case report. |
2018 |
J Med Case Rep |
pmid:29454372
|
Xu R et al. |
Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban. |
2018 |
Eur. J. Clin. Pharmacol. |
pmid:29453492
|
Tsutsui A et al. |
Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016. |
2018 |
J. Infect. Chemother. |
pmid:29428566
|
Tarhini M et al. |
First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy. |
2018 |
Microb. Pathog. |
pmid:29428426
|
Kobayashi T et al. |
The potential role of clarithromycin addition to lenalidomide and dexamethasone therapy (BiRd) in multiple myeloma. |
2018 |
Ann. Hematol. |
pmid:29427183
|
Wang S et al. |
Enhanced adsorption of ionizable antibiotics on activated carbon fiber under electrochemical assistance in continuous-flow modes. |
2018 |
Water Res. |
pmid:29426033
|
Yagbasan A et al. |
A Prospective, randomized study comparing 7-day and 14-day quadruple therapies as first-line treatments for helicobacter pylori infection in patients with functional dyspepsia. |
2018 |
Niger J Clin Pract |
pmid:29411724
|
Maiolino G et al. |
Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism. |
2018 |
Blood Press. |
pmid:29409357
|
Takahashi E et al. |
Clarithromycin suppresses induction of monocyte chemoattractant protein-1 and matrix metalloproteinase-9 and improves pathological changes in the lungs and heart of mice infected with influenza A virus. |
2018 |
Comp. Immunol. Microbiol. Infect. Dis. |
pmid:29406285
|
Zagari RM et al. |
Treatment of Helicobacter pylori infection: A clinical practice update. |
2018 |
Eur. J. Clin. Invest. |
pmid:29144559
|
Liu DS et al. |
Primary antibiotic resistance of Helicobacter pylori in Chinese patients: a multiregion prospective 7-year study. |
2018 |
Clin. Microbiol. Infect. |
pmid:29138101
|
Redondo JJ et al. |
A novel RT-PCR for the detection of Helicobacter pylori and identification of clarithromycin resistance mediated by mutations in the 23S rRNA gene. |
2018 |
Diagn. Microbiol. Infect. Dis. |
pmid:29111147
|
Iwamoto J et al. |
Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease. |
2018 |
Intern. Med. |
pmid:29093413
|
Ersoy B et al. |
The anti-inflammatory effects of erythromycin, clarithromycin, azithromycin and roxithromycin on histamine-induced otitis media with effusion in guinea pigs. |
2018 |
J Laryngol Otol |
pmid:29888693
|
Inagaki Y et al. |
Disseminated Cutaneous Infection of Mycobacterium colombiense in a Patient with Myelodysplastic Syndrome. |
2018 |
Intern. Med. |
pmid:29093379
|
De Francesco V et al. |
Quadruple, sequential, and concomitant first-line therapies for H. pylori eradication: a prospective, randomized study. |
2018 |
Dig Liver Dis |
pmid:29089267
|
Cerqueira RM et al. |
Cumulative Helicobacter Pylori Eradication Rates by Adopting First- and Second- Line Regimens Proposed by the Maastricht IV Consensus in Obese Patients Undergoing Gastric Bypass Surgery. |
2018 |
Obes Surg |
pmid:29076008
|
Haj Yahia S et al. |
Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients. |
2018 |
Rheumatol. Int. |
pmid:28975396
|
Shaharir SS et al. |
Non-tuberculous mycobacterium bacteraemia in a pregnant systemic lupus erythematosus (SLE) patient: a case review and pooled case analysis. |
2018 |
Clin. Rheumatol. |
pmid:28971307
|
Bilgilier C et al. |
Prospective multicentre clinical study on inter- and intrapatient genetic variability for antimicrobial resistance of Helicobacter pylori. |
2018 |
Clin. Microbiol. Infect. |
pmid:28669844
|
Barros S et al. |
Cat Scratch Disease: Not a Benign Condition. |
2018 |
Ocul. Immunol. Inflamm. |
pmid:28665750
|
Ullah S et al. |
Hydrophilically modified self-assembling α-tocopherol derivative as niosomal nanocarrier for improving clarithromycin oral bioavailability. |
2018 |
Artif Cells Nanomed Biotechnol |
pmid:28541761
|
Sancak S et al. |
A pioneering study: oral clarithromycin treatment for feeding intolerance in very low birth weight preterm infants. |
2018 |
J. Matern. Fetal. Neonatal. Med. |
pmid:28279123
|
Yoshida S et al. |
Association between sequevar and antibiotic treatment outcome in patients with Mycobacterium abscessus complex infections in Japan. |
2018 |
J. Med. Microbiol. |
pmid:29227218
|
Cheung KS et al. |
Long-term proton pump inhibitors and risk of gastric cancer development after treatment for : a population-based study. |
2018 |
Gut |
pmid:29089382
|
Ribaldone DG et al. |
Helicobacter pylori eradication: poor medical compliance from East to West of the world. |
2018 |
Scand. J. Gastroenterol. |
pmid:29383955
|
Suzuki K et al. |
Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare lung disease from post-marketing surveillance. |
2018 |
Respir Investig |
pmid:29325687
|